UPTD
Hello Traders
The price action declined further today . What is your opinion ?
Have a look my analysis and don’t forget to comment and like .
Thanks .
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.24 USD
−7.31 M USD
0.00 USD
10.10 M
About Estrella Immunopharma, Inc.
Sector
Industry
CEO
Cheng Liu
Website
Headquarters
Emeryville
Founded
2022
FIGI
BBG00ZDR7G05
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ESLA is 1.48 USD — it has increased by 8.76% in the past 24 hours. Watch Estrella Immunopharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Estrella Immunopharma, Inc. stocks are traded under the ticker ESLA.
ESLA stock has risen by 25.21% compared to the previous week, the month change is a 24.17% rise, over the last year Estrella Immunopharma, Inc. has showed a 39.10% increase.
We've gathered analysts' opinions on Estrella Immunopharma, Inc. future price: according to them, ESLA price has a max estimate of 16.00 USD and a min estimate of 16.00 USD. Watch ESLA chart and read a more detailed Estrella Immunopharma, Inc. stock forecast: see what analysts think of Estrella Immunopharma, Inc. and suggest that you do with its stocks.
ESLA reached its all-time high on Sep 1, 2023 with the price of 33.00 USD, and its all-time low was 0.63 USD and was reached on Oct 31, 2024. View more price dynamics on ESLA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ESLA stock is 25.35% volatile and has beta coefficient of 0.93. Track Estrella Immunopharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Estrella Immunopharma, Inc. there?
Today Estrella Immunopharma, Inc. has the market capitalization of 53.91 M, it has increased by 4.11% over the last week.
Yes, you can track Estrella Immunopharma, Inc. financials in yearly and quarterly reports right on TradingView.
Estrella Immunopharma, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ESLA net income for the last quarter is −3.38 M USD, while the quarter before that showed −3.95 M USD of net income which accounts for 14.54% change. Track more Estrella Immunopharma, Inc. financial stats to get the full picture.
No, ESLA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ESLA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Estrella Immunopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Estrella Immunopharma, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Estrella Immunopharma, Inc. stock shows the neutral signal. See more of Estrella Immunopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.